Follow this preprint

Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization

José F. Varona, Pedro Landete, Jose A. Lopez-Martin, Vicente Estrada, Roger Paredes, Pablo Guisado-Vasco, Lucía Fernández de Orueta, Miguel Torralba, Jesús Fortún, Roberto Vates, José Barberán, Bonaventura Clotet, Julio Ancochea, Daniel Carnevali, Noemí Cabello, Lourdes Porras, Paloma Gijón, Alfonso Monereo, Daniel Abad, Sonia Zúñiga, Isabel Sola, Jordi Rodon, Nuria Izquierdo-Useros, Salvador Fudio, María José Pontes, Beatriz de Rivas, Patricia Girón de Velasco, Belén Sopesén, Antonio Nieto, Javier Gómez, Pablo Avilés, Rubin Lubomirov, Kris M. White, Romel Rosales, Soner Yildiz, Ann-Kathrin Reuschl, Lucy G. Thorne, Clare Jolly, Greg J. Towers, Lorena Zuliani-Alvarez, Mehdi Bouhaddou, Kirsten Obernier, Luis Enjuanes, Jose M. Fernández-Sousa, Plitidepsin – COVID - 19 Study Group, Nevan J. Krogan, José M. Jimeno, Adolfo García-Sastre
doi: https://doi.org/10.1101/2021.05.25.21257505

Article Information

doi 
https://doi.org/10.1101/2021.05.25.21257505
History 
  • May 25, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. José F. Varona1,2,*,
  2. Pedro Landete3,4,
  3. Jose A. Lopez-Martin5,
  4. Vicente Estrada6,7,
  5. Roger Paredes8,9,
  6. Pablo Guisado-Vasco10,11,
  7. Lucía Fernández de Orueta11,12,
  8. Miguel Torralba13,14,
  9. Jesús Fortún15,
  10. Roberto Vates12,
  11. José Barberán1,2,
  12. Bonaventura Clotet8,9,16,17,
  13. Julio Ancochea3,4,18,
  14. Daniel Carnevali10,11,
  15. Noemí Cabello19,
  16. Lourdes Porras20,
  17. Paloma Gijón21,
  18. Alfonso Monereo12,
  19. Daniel Abad11,12,
  20. Sonia Zúñiga22,
  21. Isabel Sola22,
  22. Jordi Rodon23,
  23. Nuria Izquierdo-Useros24,25,
  24. Salvador Fudio26,
  25. María José Pontes27,
  26. Beatriz de Rivas27,
  27. Patricia Girón de Velasco5,
  28. Belén Sopesén5,28,29,
  29. Antonio Nieto30,
  30. Javier Gómez30,
  31. Pablo Avilés31,
  32. Rubin Lubomirov26,
  33. Kris M. White32,33,
  34. Romel Rosales32,33,
  35. Soner Yildiz32,33,
  36. Ann-Kathrin Reuschl34,
  37. Lucy G. Thorne34,
  38. Clare Jolly34,
  39. Greg J. Towers34,
  40. Lorena Zuliani-Alvarez35,36,37,38,
  41. Mehdi Bouhaddou35,36,37,38,
  42. Kirsten Obernier35,36,37,38,
  43. Luis Enjuanes22,
  44. Jose M. Fernández-Sousa39,
  45. Plitidepsin – COVID - 19 Study Group‡,
  46. Nevan J. Krogan32,35,36,37,38,*,
  47. José M. Jimeno5,† and
  48. Adolfo García-Sastre32,33,40,41,†,*
  1. 1Departamento de Medicina Interna, Hospital Universitario HM Monteprincipe, HM Hospitales, Madrid, Spain
  2. 2Facultad de Medicina, Universidad San Pablo-CEU, Madrid, Spain
  3. 3Hospital Universitario La Princesa, Madrid, Spain
  4. 4Universidad Autónoma de Madrid, Madrid, Spain
  5. 5Virology & Inflammation Unit, PharmaMar, S.A., Colmenar Viejo, Madrid, Spain
  6. 6Hospital Clínico San Carlos, Madrid, Spain
  7. 7Universidad Complutense de Madrid, Madrid, Spain
  8. 8Infectious Diseases Department, irsiCaixa AIDS Research Institute, Badalona, Barcelona, Spain
  9. 9Hospital Germans Trias I Pujol, Badalona, Barcelona, Spain
  10. 10Internal Medicine Department. Hospital Universitario Quironsalud Madrid, Madrid, Spain
  11. 11Universidad Europea, Madrid, Spain
  12. 12Internal Medicine Department, Hospital Universitario de Getafe, Madrid, Spain
  13. 13Health Sciences Faculty, University of Alcalá, Madrid, Spain
  14. 14Guadalajara University Hospital, Guadalajara, Spain
  15. 15Hospital Universitario Ramón y Cajal, Madrid, Spain
  16. 16Universitat Autònoma de Barcelona, Barcelona, Spain
  17. 17Universitat de Vic, Universitat Central de Catalunya Barcelona, Spain
  18. 18Centro de Investigación en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII), Madrid
  19. 19Infectious Diseases Department, Clinico San Carlos University Hospital, Madrid, Spain
  20. 20Internal Medicine, Hospital General de Ciudad Real, Ciudad Real, Spain
  21. 21Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
  22. 22Department of Molecular and Cell Biology, Centro Nacional de Biotecnología (CNB-CSIC), Madrid, Spain
  23. 23IRTA, Centre de Recerca en Sanitat Animal (CReSA, IRTA-UAB), Campus de la UAB, Bellaterra, Spain
  24. 24IrsiCaixa AIDS Research Institute, Badalona, Barcelona, Spain
  25. 25Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelone, Spain
  26. 26Clinical Pharmacology Unit, PharmaMar, Colmenar Viejo, Madrid, Spain
  27. 27Medical Affairs, PharmaMar, Colmenar Viejo, Madrid, Spain
  28. 28Sylentis, S.A.U., Tres Cantos, Madrid, Spain
  29. 29Biocross, S.L., Valladolid, Spain
  30. 30Bio Statistics Unit, PharmaMar, Colmenar Viejo, Madrid, Spain
  31. 31Preclinical Unit, Pharmamar, Colmenar Viejo, Madrid, Spain
  32. 32Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
  33. 33Global Health Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
  34. 34Division of Infection and Immunity, University College London, London WC1E 6BT, United Kingdom
  35. 35Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA 94158, USA
  36. 36J. David Gladstone Institutes, San Francisco, CA 94158, USA
  37. 37Quantitative Biosciences Institute (QBI), Coronavirus Research Group (QCRG), San Francisco, CA 94158, USA
  38. 38Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94518, USA
  39. 39Pharmamar, Colmenar Viejo, Madrid, Spain
  40. 40Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA
  41. 41Tish Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
  1. ↵*Corresponding author. Email: jfvarona{at}hmhospitales.com (J.F.V.); Adolfo.Garcia-Sastre{at}mssm.edu (A.G-S.); Nevan.Krogan{at}ucsf.edu, (N.J.K.)

  1. ↵† These authors contributed equally to this work.

Back to top
Posted May 25, 2021.
Download PDF
Print/Save Options
Download PDFFull Text & In-line FiguresXML

Supplementary Material

Data/Code
Email
Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization
José F. Varona, Pedro Landete, Jose A. Lopez-Martin, Vicente Estrada, Roger Paredes, Pablo Guisado-Vasco, Lucía Fernández de Orueta, Miguel Torralba, Jesús Fortún, Roberto Vates, José Barberán, Bonaventura Clotet, Julio Ancochea, Daniel Carnevali, Noemí Cabello, Lourdes Porras, Paloma Gijón, Alfonso Monereo, Daniel Abad, Sonia Zúñiga, Isabel Sola, Jordi Rodon, Nuria Izquierdo-Useros, Salvador Fudio, María José Pontes, Beatriz de Rivas, Patricia Girón de Velasco, Belén Sopesén, Antonio Nieto, Javier Gómez, Pablo Avilés, Rubin Lubomirov, Kris M. White, Romel Rosales, Soner Yildiz, Ann-Kathrin Reuschl, Lucy G. Thorne, Clare Jolly, Greg J. Towers, Lorena Zuliani-Alvarez, Mehdi Bouhaddou, Kirsten Obernier, Luis Enjuanes, Jose M. Fernández-Sousa, Plitidepsin – COVID - 19 Study Group, Nevan J. Krogan, José M. Jimeno, Adolfo García-Sastre
medRxiv 2021.05.25.21257505; doi: https://doi.org/10.1101/2021.05.25.21257505
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area

Reviews and Context

1

Comment

0

TRIP Peer Reviews

0

Community Reviews

0

Automated Services

6

Blogs/Media

0

Author Videos

You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the medRxiv Alerts Page.

Sign In to Follow this Preprint

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.